Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Hepatorenal syndrome: Current concepts and future perspectives

Chan-Young Jung, Jai Won Chang

Clin Mol Hepatol. 2023;29(4):891-908. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0024

View: 9505 Download: 1,336 Web of Science: 8 Crossref: 9

Case Report

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome

Hae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L. Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choi

Clin Mol Hepatol. 2013;19(4):417-420. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.417

View: 9089 Download: 117 Crossref: 8

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Heon Ju Lee, Myung Jin Oh

Clin Mol Hepatol. 2013;19(2):179-184. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.179

View: 8111 Download: 83 Crossref: 10

7

The Korean Journal of Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

Oh Sang Kwon, M.D.

Clin Mol Hepatol. 2010;16(1):100-102. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.100

View: 4087 Download: 31

3

Comparison of Terlipressin and Octreotide with Variceal Ligation for Controlling Acute Esophageal Variceal Bleeding - a Randomized Prospective Study

Sung Bum Cho , Kang Jin Park , Jung Soo Lee , Wan Sik Lee , Chang Hwan Park , Young Eun Joo , Hyun Soo Kim , Sung Kyu Choi , Jong Sun Rew , Sei Jong Kim

Clin Mol Hepatol. 2006;12(3):385-393. Published online January 1, 2000

View: 4097 Download: 170

A Prospective Study Comparing the Efficacy of Early Administration of Terlipressin and Somatostatin for the Control of Acute Variceal Bleeding in Patients with Cirrhosis

Yeon Seok Seo, M.D., Soon Ho Um, M.D., Jong Jin Hyun, M.D., Youn Ho Kim, M.D., Sanghoon Park, M.D., Bo Ra Keum, M.D., Yong Sik Kim, M.D., Yoon Tae Jeen, M.D., Hong Sik Lee, M.D., Hoon Jai Chun, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D., and Ho Sang Ryu, M.D.

Clin Mol Hepatol. 2006;12(3):373-384. Published online January 1, 2000

View: 3605 Download: 87

1 |

Viewed By 7410	MAFLD: How is it different from NAFLD?
Viewed By 6995	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5604	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5360	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4788	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search